Meeting
2014 Gastrointestinal Cancers Symposium
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
Authors
Ramon Salazar
Translational Research Laboratory and Department of Medical Oncology, Institut Catala d'Oncologia-IDIBELL, Hospitalet de Llobregat, Spain
Ramon Salazar , Jaume Capdevila , Robert Rosenberg , Jan Willem de Waard , Bengt Glimelius , Frederic Bibeau , Joost Klaase , Jacobus JM Van der Hoeven , Rachel A Midgley , George J. Chang , Thomas Bachleitner-Hofmann , Michio Asano , Reinhard Ziebermayr , Edward Allen Levine , Kenneth B. Deck , Jamie Sington , Wai Lun Law , Imad Shbeeb , Lisette Stork , John Marshall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Clinical Trial Registration Number
NCT00903565
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 465)
DOI
10.1200/jco.2014.32.3_suppl.465
Abstract #
465
Poster Bd #
B28
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
First Author: Ramon Salazar
Poster
2011 Gastrointestinal Cancers Symposium
The PARSC trial: A prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 Gastrointestinal Cancers Symposium
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar